United States Diphtheria Vaccine Market Applications, Specifications and Market Threats Forecast Till 2025

United States Diphtheria Vaccine Market is expected to grow at the highest CAGR in the upcoming period. Diphtheria vaccine is administered for infectious diseases in humans. Diphtheria is a serious disease caused by bacteria called “Corynebacterium diphtheriae”. Diphtheria is a bacterial infection that mainly affects the nose, throat, and mouth of an infected person and could be passed to others by sneezing or coughing. Diphtheria could lead to severe heart problems, breathing problems, and paralysis. Diphtheria vaccine is administered either in childhood or middle age to produce the acquired immunity against diphtheria. The diphtheria vaccine is very safe.

Browse Detail TOC of United States Diphtheria Vaccine Market at:
https://www.millioninsights.com/industry-reports/united-states-diphtheria-vaccine-market

The factors responsible for the growth of United States diphtheria vaccine market are increasing demand for vaccinations, advancements in vaccine delivery devices, development of technologically advanced vaccines, and concerns about health issues. The other factors include rising prevalence of chronic disease and increasing usage of therapy and vaccine. However, side effects, lack of accuracy, complications during inhalation, and high prices of devices are likely to negatively impact the growth of industry.

United States diphtheria vaccine industry is categorized based on product, vaccine type, age group, end user, and geography. Based on product, the United States diphtheria vaccine market is classified as DT, DTaP, Td, and Tdap. The segment “DTaP” is sub-divided into Infanrix, Daptacel, Pediarix, Kinrix, Pentacel and Quaracel. Also, the segment “Tdap” is sub-divided by Adacel and Boostrix. Similarly, “Td” segment is sub-divided by Tenivac and Decavac.

Based on vaccine type, the United States diphtheria vaccine industry is classified as a cellular vaccine and whole-cell vaccine. Based on age group, the market is classified as for infants & children younger than seven years of age and for adolescents & adults. Based on end user, the industry is classified as clinics, hospitals, and vaccination centers. Based on geography, the market spans Southwest, The Middle Atlantic, The West, New England, The South, and The Midwest.

Request Free Sample Copy of United States Diphtheria Vaccine Market Research Report at:
https://www.millioninsights.com/industry-reports/united-states-diphtheria-vaccine-market/request-sample

Key players operating in the United States diphtheria vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck, Wyeth (Pfizer), Changchun Changsheng Life Sciences, Novartis, Shanghai Institute of Biological Products, Beijing Tiantan Biological Products, Wuhan Institute of Biological Products, and Chengdu Institute of Biological Products.